RankAlpha logo
Back to Rankings

CYCN

Cyclerion TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
CYCN vs peer average
54/100
CYCN vs. peer average (D vs. D)
Grade spread
B 1 · C 1 · D 1 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

MBRX is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $13.13M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerMBRXMoleculin Biotech
CYCN
Cyclerion Therapeutics
MBRX
Moleculin Biotech
Grade
D
F
Momentum
43
67
Value
42
41
Sentiment
-
0
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs MBRX

CYCN / MBRX
Grade Position
In line
CYCN vs. peer average (D vs. D)
54/100
Momentum
43
MBRX
Value
42
CYCN
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CYCN
1
MBRX
Moleculin Biotech Inc Common
F
20/100
+1
2
PHIO
Phio Pharmaceuticals Corp Common
B
80/100
-2
3
BFRI
Biofrontera Inc Common
F
20/100
+1
4
BIVI
BioVie Inc Class A Common
F
20/100
+1
5
GDTC
CytoMed Therapeutics Ltd Common
D
40/100
Even
MBRX is the first peer returned for this comparison set.